MMP3 and benign prostatic hyperplasia: Similarly, patients with low-grade tumors (Gleason score ≤ 7) had a higher serum MMP-3 level (21,096 ± 10,023 pg/ml, n = 8) than did patients with BPH, but the difference was in the margin of significance (p = 0.0523).